Cargando…
Should remdesivir be recommended in France in the early stage of COVID-19
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720377/ https://www.ncbi.nlm.nih.gov/pubmed/34986405 http://dx.doi.org/10.1016/j.ijid.2021.12.359 |
| _version_ | 1784625115301937152 |
|---|---|
| author | Martin, Martinot |
| author_facet | Martin, Martinot |
| author_sort | Martin, Martinot |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8720377 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The Author. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87203772022-01-03 Should remdesivir be recommended in France in the early stage of COVID-19 Martin, Martinot Int J Infect Dis Perspective The Author. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022-03 2022-01-02 /pmc/articles/PMC8720377/ /pubmed/34986405 http://dx.doi.org/10.1016/j.ijid.2021.12.359 Text en © 2022 The Author Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Perspective Martin, Martinot Should remdesivir be recommended in France in the early stage of COVID-19 |
| title | Should remdesivir be recommended in France in the early stage of COVID-19 |
| title_full | Should remdesivir be recommended in France in the early stage of COVID-19 |
| title_fullStr | Should remdesivir be recommended in France in the early stage of COVID-19 |
| title_full_unstemmed | Should remdesivir be recommended in France in the early stage of COVID-19 |
| title_short | Should remdesivir be recommended in France in the early stage of COVID-19 |
| title_sort | should remdesivir be recommended in france in the early stage of covid-19 |
| topic | Perspective |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720377/ https://www.ncbi.nlm.nih.gov/pubmed/34986405 http://dx.doi.org/10.1016/j.ijid.2021.12.359 |
| work_keys_str_mv | AT martinmartinot shouldremdesivirberecommendedinfranceintheearlystageofcovid19 |